Context Therapeutics Inc. CNTX

Full chart Compare
Set alert

Price alert · CNTX

All alert types
0.19 USD -0.01 (-3.96%)

At closeNov 3, 2026, 5:06 PM EST

0.21 +0.02 +7.99%

After hours · Nov 3, 5:06 PM ET

0.1907 Day range 0.2096
0.189 52-week range 3.62
YTD
-86.80%
1 year
-82.04%

Analyst view

Price target (mean) 7.70 +3869.1% upside
Target (low)
4.50
Target (mean)
7.70
Target (high)
10.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy3
  • Buy2
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CNTX analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.05-0.06 – -0.04-0.42+88.1%00.0%4
Next quarter-0.06-0.06 – -0.06-0.23+73.9%00.0%1
Current year-0.51-0.53 – -0.49-1.50+66.0%00.0%4
Next year-0.3025-0.37 – -0.24-0.51+40.7%00.0%5

Upgrades and downgrades

The latest rating changes

CNTX analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2024D. Boral CapitalInitiated—Buy
Sep 23, 2024HC Wainwright & Co.ReiteratedBuyBuy
Sep 16, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 16, 2024Piper SandlerInitiated—Overweight
May 9, 2024HC Wainwright & Co.MaintainedBuyBuy
May 9, 2024Maxim GroupMaintainedBuyBuy
Mar 21, 2024HC Wainwright & Co.MaintainedBuyBuy
Nov 1, 2023HC Wainwright & Co.UpgradeNeutralBuy
Sep 11, 2023Maxim GroupInitiated—Buy
Jun 6, 2023HC Wainwright & Co.Reiterated—Neutral
Mar 23, 2023HC Wainwright & Co.DowngradeBuyNeutral
Feb 7, 2023HC Wainwright & Co.Reiterated—Buy
Feb 2, 2022HC Wainwright & Co.Initiated—Buy
Jan 24, 2022ThinkEquityInitiated—Buy